ClinVar Miner

Submissions for variant NM_013382.5(POMT2):c.1006+5G>A (rs587780422)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
EGL Genetic Diagnostics,Eurofins Clinical Diagnostics RCV000725964 SCV000340882 uncertain significance not provided 2016-03-29 criteria provided, single submitter clinical testing
GeneDx RCV000725964 SCV000617438 uncertain significance not provided 2017-10-18 criteria provided, single submitter clinical testing The c.1006+5 G>A variant has been reported previously in an individual with Walker-Warburg syndrome who had a second POMT2 variant identified; however, parental studies were not performed (Manzini et al., 2008). The c.1006+5 G>A variant is observed in 5/111,398 (0.004%) alleles from individuals of European background (Lek et al., 2016). The c.1006+5 G>A variant is predicted to destroy the natural splice donor site in intron 8. However, in the absence of RNA/functional studies, the actual effect of this sequence change in this individual is unknown. Based on the currently available information, it is unclear whether this variant is a pathogenic variant or a rare benign variant.
Genetic Services Laboratory, University of Chicago RCV000118039 SCV000152364 likely pathogenic Limb-girdle muscular dystrophy-dystroglycanopathy, type C2 2014-01-17 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.